Medication info

Eglidine Tablets 2mg (Irsogladine Maleate)

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Irsogladine Maleate›2mg / 1 tablet
Manufacturer / importer
Daewoong Pharmaceutical Co., Ltd.
Appearance
White round tablets
Packaging
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 202000749 · Approved 2020.02.10

This product's status changed to Approval withdrawn on 2024.02.07. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastric ulcers; improvement of gastric mucosal lesions in acute gastritis and during acute exacerbations of chronic gastritis
Who takes it
Adults
Adult dose
1) Gastric ulcer (Adults) Administer 4mg of irsogladine maleate orally once daily. 2) Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis (Adults) Administer 4mg of irsogladine maleate orally in 1∼2 divided doses daily.

Ingredients

Manufacturer
Daewoong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastric ulcers; improvement of gastric mucosal lesions in acute gastritis and during acute exacerbations of chronic gastritis

  • Gastric ulcers
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
  • acute gastritis
  • acute exacerbation of chronic gastritis
View approved original text

This medication is used for the treatment of gastric ulcers and helps improve lesions such as erosion, bleeding, redness, and swelling of the gastric mucosa during acute exacerbations of acute and chronic gastritis. Therefore, it is effective in restoring mucosal damage in the stomach and alleviating symptoms.

How to take

Adult dose

1) Gastric ulcer (Adults) Administer 4mg of irsogladine maleate orally once daily. 2) Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis (Adults) Administer 4mg of irsogladine maleate orally in 1∼2 divided doses daily.

Precautions

This medicine contains lactose and should not be used by individuals with genetic disorders that affect lactose digestion. During treatment, side effects such as liver dysfunction, constipation, rash, itching, and diarrhea may occur. Rarely, abnormal symptoms such as dizziness, drowsiness, decreased appetite, or changes in blood test values have been reported. Elderly individuals may have decreased bodily functions, therefore, treatment should start with a lower dose while carefully monitoring their condition. Women who are pregnant or may become pregnant should only use this medicine if the benefits outweigh the risks, as safety during pregnancy is not established. Breastfeeding women should avoid this medicine since it may be passed into breast milk, and if it must be taken, nursing should be discontinued. Safety in children has not been sufficiently established, so it should be used with caution in pediatric patients. This medicine should be kept out of reach of children, and care should be taken not to transfer it into other containers, as this may lead to accidents or degradation in quality. The half-life of this medicine in the body is approximately 150 hours, which is relatively long.

Side effects

  • Liver dysfunction
  • elevated ALT (GPT)
  • elevated AST (GOT)
  • constipation
  • rash
  • pruritus
  • diarrhea
  • elevated ALP
  • nausea
  • vomiting
Show 39 more
  • erythema
  • eczema
  • polymorphic light eruption
  • edema erythema
  • chest tightness
  • fever
  • dizziness
  • drowsiness
  • abdominal distension
  • loss of appetite
  • thirst
  • elevated serum Cl
  • leukocytosis
  • elevated BUN
  • elevated total bilirubin
  • positive occult blood
  • nausea
  • dyspepsia
  • epigastric pain
  • gastroesophageal reflux
  • increased SGPT
  • increased SGOT
  • duodenitis
  • hematochezia
  • acute cholecystitis
  • bile duct cancer
  • exacerbation of malignancy
  • palpitations
  • brain metastasis
  • heartburn
  • hematemesis
  • belching
  • fatty liver
  • abdominal pain
  • edema
  • worsening cough
  • upper respiratory infection
  • joint abnormalities
  • headache

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius to preserve its effectiveness.

Appearance and packaging

Appearance

White round tablets

Package unit

Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.